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Abstract 
Background: It is a well-known fact that both statins and exercise have 
beneficial effects in preventing cardiovascular disease; however, no 
information is available about their combinatorial effect on the cardiac 
cell apoptosis and protein expression of SDF-1α/CXCR4 after 
myocardial infarction (MI). This study aimed to evaluate the combined 
effect of endurance training and atorvastatin on the apoptosis and 
protein expression of SDF-1α/CXCR4 in the cardiac tissue of rats 
following MI. 
Methods: In total, 30 rats (8–10 weeks old, weighing 220–240 g) were 
randomly divided into five groups. Myocardial infarction was induced 
by subcutaneous injection of isoprenaline (150 mg/kg) in 2 consecutive 
days. Drug and training intervention was initiated 2 days after 
infarction and was continued for 4 weeks. To assess apoptotis and 
protein expression of SDF-1α/CXCR4 axis, Tunnel and IHC staining 
were performed, respectively. 
Results: The combination of endurance exercise and atorvastatin 
significantly reduced the number of apoptotic cells and increased the 
protein expression of SDF-1α compared with the other groups 
(P<0.001). Moreover, this combination significantly increased the 
protein expression of CXCR4 compared with the control and sham 
groups (P<0.001) and with the atorvastatin group (P<0.05). 
Endurance exercise training and atorvastatin, individually induced a 
significant decrease in the apoptotic cell count (P<0.001) and 
nonsignificant increase in the protein expression of SDF-1/CXCR4, 
compared with the control group.  
Conclusions: Results of this study revealed that the combined effects of 
training and atorvastatin are more efficient in reducing the apoptosis 
and upregulation of SDF-1α/CXCR4 than exercise or atorvastatin 
alone. 
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Introduction 
Cardiovascular disease is the leading cause of mortality 
worldwide.1 Approximately, each year 17.1 million people die 
due to cardiovascular disease, of which about 7.2 million 
deaths result from myocardial infarction (MI).2 MI occurs as a 
result of insufficient blood flow, hypoxia, and reduction of 
glucose availability to the cardiac tissue. The acute and chronic 
disorders of MI can lead to cell damage3 and induce apoptosis.4 
Apoptosis occurs about 4.5 h after infarction; however, several 
months after the myocardial infarction, the cardiac cell death in 
the surroundings of the infarcted area is mainly attributed to 
apoptosis.5 
Following ischemia, high speed angiogenesis begins.6 CXC 
chemokine family, including the stromal cell-derived factor-1 
alpha (SDF-1α) is a key regulator of angiogenesis that binds to 
the cognate CXCR4 receptor on the stem and progenitor cells 
and plays a crucial role in gathering and recruitment of stem 
cells into the infarcted area.7 Studies reveal that SDF-1α 
induced mobilization of the bone marrow-derived stem cells to 
the ischemic area, leads to angiogenesis and improves cardiac 
function.8 It is reported that the treatment by SDF-1α after 
myocardial infarction, exerts beneficial effects on the 
ventricular function by recruiting bone marrow or circulating 
hematopoietic stem cells and presumably by inhibiting the 
apoptosis of cardiac cells and enhancing angiogenesis.8 
Expression of SDF-1α and CXCR4 after myocardial infarction 
is a transitory process that peaks 2 days after infarction and 
returns to sham levels 28 days after infarction9 Therefore, the 
brief and temporary upregulation of SDF-1α after acute 
myocardial infarction seems insufficient for complete recovery 
of cardiac function.10 Till date, numerous methods are 
investigated to protect the heart against ischemic injury. 
Pharmacological intervention, especially using statin drugs for 
strengthening the expression of angiogenic factors such as the 
eNOS/NO and SDF-1α/CXCR4 axis, as well as for reducing 
the isoprenoide synthesis and apoptosis, are recognized as most 
effective methods in improving the body’s innate ability to 
develop lateral vessels as well as in reducing the ischemic 
complications such as cardiac remodeling and extending the 
infarcted area.10 It is reported that statins can be used to 
strengthen the SDF-1α expression instantly after ischemic 
damage. Moreover, studies report that these drugs stabilize 
eNOS mRNA and increased production of nitric oxide (NO), 
and thereby exert antiapoptotic effects in patients with 
cardiovascular disease.10 Qiu et al. (2012) also reported that the 
expression of SDF-1α and CXCR4 was significantly increased 
after 7 days of treatment by atorvastatin.10 
Furthermore, the animal studies suggest that regular 
sessions of aerobic exercise, protects the heart against ischemia 
or reperfusion injury.11,12 Benefits of exercise on the metabolic, 
cardiovascular, and anti-inflammatory factors, has led many 
investigators to suggest exercise training as a 
nonpharmaceutical tool in the prevention and treatment of 
cardiovascular disease. The efficiency of exercise training as a 
powerful tool in the treatment of abnormalities associated with 
myocardial infarction is widely reported in clinical and 
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experimental conditions.13 Some protective effects of 
endurance exercise training include lateral vessel formation, 
increase heat shock proteins (HSPs), expression of myocardial 
cyclooxygenase (COX), increased antioxidant and anti-
inflammatory status, ER stress proteins, expression and activity 
of eNOS/NO system, and an increase in the angiogenic factors 
such as SDF-1α and VEGF;11,13-15 however, the effects of 
exercise training after MI on cardiac cell apoptosis still remain 
unclear.16 
As aforementioned, it is clear that statins (including 
atorvastatin), and also endurance exercise training may be 
effective in secondary prevention after myocardial infarction. 
Hence, it is likely that the simultaneous use of statin drugs and 
endurance training may be more efficient in the treatment and 
prevention of cardiovascular disorders such as myocardial 
infarction. 
Materials and Methods  
Thirty adult male Wistar rats (8–10 weeks old, 230±10 g 
body weight) were obtained from Tehran Pasteur Institute and 
housed in standard cages and controlled environment (22–24 
°C, 45–50% humidity, and 12-h light/dark cycle), with free 
access to food and water. All experiments were performed in 
accordance with the Helsinki Declaration. Rats were randomly 
divided into five groups. Sham, control, endurance training, 
atorvastatin, and exercise+atorvastatin groups (6 rats per group). 
MI Induction: Isoprenaline solution in normal saline was 
injected SC at a dose of (150 mg/kg) on two consecutive days 
with an interval of 24 h for MI induction.17,18 
Study design and data collection: According to figure 1, 
training and pharmaceutical intervention began 2 days after MI. 
Training groups initiated the core training program at a speed 
of 10 m/min, for 10 min, once a day, for 5 sessions a week. The 
speed and duration of training were gradually increased to 16 
m/min and 50 min/day (including a 5 min warm-up at 10 
m/min) by the end of the second week; the intensity and 
duration were maintained constant throughout the experiment. 
Endurance exercise protocol continued for 4 weeks. The 
intensity of exercise is average about 55% of VO2 max (the 
maximum volume of oxygen consumption and is the best index 
for determining the intensity of exercise training.19,20 Other 
groups were placed on the device for 5 min once a day at a 
speed of 5 m/min daily. Moreover, the drug intervention 
groups, 48 h after induction of myocardial infarction, received 
daily atorvastatin dissolved in saline (1 mg/ml/) and were then 
orally gavaged by a dose of 10 mg/kg of body weight.10 Other 
groups received similar amount of normal saline. On 48 h after 
the last training session (28 days after infarction), the rats were 
anesthetized using chloroform and their hearts were removed 
under deep anesthesia; they were washed by saline and were 
placed in formalin as a fixative. After 24 h, the hearts were cut 
longitudinally and were immersed in molten paraffin. After 
preparing the paraffin blocks using microtome, 6 µm thick 
sections were prepared and mounted on the glass slides. To 
evaluate the cell apoptosis, tunnel staining, and the protein 
expression of SDF-1α/CXCR4, IHC staining was performed. 
After staining, the samples were studied using an optical 
microscope (Olympus AX-70) at 400× magnifica-tion. 
 
Figure 1. The outline of research 
To detect the apoptotic cells, TUNEL assay (terminal 
deoxy nucleotidyl transferase mediated dUTP nick end 
labeling) was performed according to manufacturer’s 
instructions (Roche, Germany). In brief, the sections were 
incubated at 60 °C, washed, and then rehydrated by successive 
series of alcohol, rinsed in PBS, and treated by 10 mM 
proteinase K for 30 min at room temperature. Subsequently, to 
block the endogenous peroxidase activity, the sections were 
washed and incubated with 3% H2O2 in methanol for 10 min 
in a dark place. Moreover, TUNEL reaction mixture was added 
to the sections and incubated for 60 min at 37 °C in a chamber 
with moderate humidity, followed by rinsing with PBS and 
visualization was executed using converter-POD for 30 min at 
37 °C in a dark place with appropriate humidity. In the next 
stage, the sections were washed with PBS and 50 μl of DAB 
substrate (0.05% 3, 3-diaminobenzidine) as a chromogen was 
added to the sections and incubated for 10 min at room 
temperature. Eventually, the slides were washed with PBS, 
placed in hematoxylin for counter stain and were mounted by a 
cover slip. The visible TUNEL positive cells in dark brown 
were quantified by light microscope Olympus at 40× 
magnification. In each slide, five random fields were examined 
and the apoptotic cells were visually counted in each field. The 
average of five studied regions was considered as the number 
of apoptotic cells per slide. All counting procedures were 
blindly performed. 
In summary, the paraffin-embedded sections were moved 
to the slides after preparation. In the next step, the sections 
were placed in three containers with xylol for deparaffinization 
of each sample for 5 min. Furthermore, by descending the 
concentration of alcohol in series, the samples were rehydrated, 
washed in Tris buffer (PH 7.4), and antigens were retrieved by 
heating the sections (autoclave 120 °C) in citrate buffer 
solution (PH 6). In order to reduce the activity of the 
endogenous enzymes, the sections were placed in a solution of 
10% hydrogen peroxide (H2O2/methanol) for 10 min. 
Moreover, the sections were incubated with primary antibody 
(UK, Biorbyt) overnight at 4 °C. Optimal dilution was found to 
be 1/100 for SDF-1α (1/100) and 1/200 for CXCR4 (1:200). 
Then the sections were washed in PBS buffer and incubated for 
30 min at room temperature with secondary antibody HRP 
(1/1000), following incubation with 1% DAB solution (3, 
3’diaminobenzidin, Sigma, USA) in the dark for 10 min and 
counter staining with hematoxylin solution. Finally, the 
sections were dehydrated in ascending alcohol series and were 
cleared with xylene. Regions of tissue that reveal protein 
expression of the relevant markers are visible in brown. 
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To analyze the protein expression of SDF-1α and CXCR4, 
the images of four randomly selected fields in each section 
were prepared by light microscope Olympus (400×). In each 
field, the cells revealing positive protein expression of relevant 
markers were counted. Moreover, using image analyzer 
software ImageJ, the ratio of positive cells to the total cells in 
each image was extracted. Average of four assessed areas was 
recorded as the percentage of protein expression of relevant 
marker in each slide. 
For data analysis, SPSS version 16 and descriptive and 
inferential statistics were used. All results are reported as a 
mean±SD. The Kolmogorov-Smirnov test was used to verify 
the normality of the distribution. One-way analysis of variance 
(ANOVA) test was used to compare the differences between 
the groups. When a significant difference was revealed, the 
Scheffe's post hoc test was used to specify where the difference 
occurred. A value of P≤0.05 was considered as statistically 
significant. All data were analyzed by the SPSS software 
(SPSS for windows; version 16.00). A value of P≤0.05 was 
considered as statistically significant. All data were analyzed 
by the SPSS software (SPSS for windows; version 16.00). 
Results 
The results indicated that experimental myocardial 
infarction induces cell apoptotis in the cardiac muscle. The 
results also revealed that the number of apoptotic cells in the 
exercise training (16.17±1.47), atorvastatin (16.17±0.75), and 
exercise+atorvastatin (12±1.41) groups significantly decreased 
compared to the control group (22±0.63, P<0.001). The 
difference between the training and atorvastatin groups was not 
significant in terms the apoptotic cell count; however, the 
difference between the exercise+atorvastatin group and the 
atorvastatin and training groups alone is significant (P<0.001; 
figure 2).  
 
Figure 2. The number of TUNEL-positive cells in the study groups.(A) sham, (B) 
control, (C) exercise, (D) atorvastatin, (E) exercise+atorvastatin. The number of 
apoptotic cells in exercise training, atorvastatin, and exercise+atorvastatin 
groups decreased significantly compared to the control group. (Arrows 
indicate the active TUNEL-positive cells, Magnifications 400×). 
* Significantly different compared with control and sham groups (P<0.001). 
# Significantly different compared with control and sham groups (P<0.001). 
¥ Significantly different compared with sham, control, exercise, and 
atorvastatin groups (P<0.001). 
Moreover, in case of SDF-1α protein expression, the results 
revealed that the difference between the exercise training 
(5.80±0.31), control (5.58±0.28), sham (5.21±0.23), and 
atorvastatin (5.61±0.09) groups was not statistically significant; 
however, the difference between the exercise+atorvastatin 
group (6.52±0.38) compared with other groups was significant 
(P<0.001; figure 3).  
 
Figure 3. SDF1α-positive cells in the study groups. (A) sham, (B) control, (C) 
exercise, (D) atorvastatin, (E) exercise +atorvastatin. The combined 
intervention of endurance training and atorvastatin significantly increased the 
amount of SDF-1α-protein expression. (Arrows indicate the SDF1α-positive 
cells, Magnifications 400×). 
* Significantly different compared with other groups (P<0.001). 
Considering the protein expression of CXCR4, results 
indicated that the difference between the exercise training 
(5.47±0.39), control (5.09±0.20), sham (4.92±0.38), and 
atorvastatin (5.40±0.48) groups was not statistically significant; 
however, the difference between the exercise+atorvastatin 
group (6.19±0.41) compared with control and sham groups 
(P<0.001) as well as with the atorvastatin group (P<0.05) was 
statistically significant. Difference between exercise+atorvastatin 
group with training group alone was not statistically significant 
(figure 4). 
 
Figure 4. CRCX4-positive cells in the study groups. (A) sham, (B) control, (C) 
exercise, (D) atorvastatin, (E) exercise+atorvastatin. The combined 
intervention of endurance training and atorvastatin significantly increased the 
amount of CRCX4-protein expression. (Arrows indicate the CRCX4-positive 
cells, Magnifications 400×). 
* Significantly different compared with control and sham groups (P<0.001) and 
atorvastatin group (P<0.05). 
Azamian Jazi et al 
International Journal of Health Studies 2017;3(2)      |         13 
Discussion 
In this study, the SC injection of isoprenaline (150 mg/kg) 
significantly increased the number of apoptotic cells compared 
with the healthy control group (normal saline). Four weeks of 
endurance training and intake of atorvastatin both alone and in 
combination, significantly reduced the number of apoptotic 
cells compared to the control group; however, the combination 
of exercise and atorvastatin caused a greater reduction in the 
apoptotic cell count. Moreover, the results of IHC revealed that 
induced myocardial infarction in rats by isoprenaline, increased 
the protein expression of SDF-1α/CXCR4 axis in the cardiac 
tissue of rats 2 days after infarction. Compared with the control 
group, only the combined intervention of endurance training 
and atorvastatin significantly increased the amount of SDF-
1α/CXCR4 protein expression. This upregulation of SDF-
1α/CXCR4 axis is considered as a protective process in 
response to the tissue damage caused by infarction, and as a 
compensatory response to restore the cardiac function and 
prevent the progression of infarction. 
The results of the present study suggest beneficial effects of 
endurance training in reducing the number of apoptotic cells. 
This has been confirmed in the previous studies.21-25 The 
underlying mechanism of cardioprotective effects of physical 
exercise still remains unclear, and it presumably, the 
antiapoptotic effects of endurance training, probably due to the 
positive effect of endurance training on the antioxidant 
capacity, increased the expression and activity of antiapoptotic 
factors such as Bcl-2, and inhibited the activity of preapoptotic 
factors such as Bax and Caspases3 and 9. The exercise 
increases the production of ROS by increasing the oxygen 
consumption, whereas in the long term it strengthens the 
antioxidant defense and reduces oxidative stress.21-25 Formation 
of mitochondrial ROS is one of the crucial factors in necrotic 
and apoptotic cardiac cell death after ischemia reperfusion 
injury. Several evidences reveal that endurance exercise 
training increases various components of the tampon system in 
the heart. For example, it is known that endurance training 
increased the levels of superoxide dismutase enzymes 1 and 2 
(SOD 1, 2) in the intermembrane space and mitochondrial 
matrix. These enzymes are known as the first line of defense 
against superoxide radicals in cells, which through mutations in 
the superoxide radicals, convert them to the nonradical species, 
hydrogen peroxide (H2O2).26 These findings suggest that 
reduced apoptosis in muscles after exercise, was potentially 
associated with the increasing antioxidant capacity and 
modulating of oxidative stress levels.27 
Another possible cardioprotection mechanism of endurance 
training against apoptotis is the strengthening levels of heat 
shock proteins (HSPs). Siu et al. (2004) reported that the 
exercise-induced decrease in apoptosis is linked with increased 
levels of heat shock protein 70 (HSP-70).27 Recent findings 
have reported that regular endurance training protects the heart 
against ischemia-reperfusion induced apoptosis.21 It is also 
reported that exercise training increases the HSP-72 level 3–5 
times in the cardiac muscle.11 Previous studies suggest that 
HSP-72 mainly prevents apoptosis and increases the 
antioxidant capacity by protecting the heart against ischemia-
reperfusion injury.11,28 
Another finding of this study is that atorvastatin 
significantly reduced the apoptotic cell count. 
The gradual loss of cardiac cells as a result of apoptosis is 
one of the most important pathogenic factors in heart failure. 
Therefore, the reduced loss of heart cells through inhibition of 
apoptosis has important implications in the treatment of heart 
failure.  
Stress may lead to apoptosis in the endoplasmic reticulum. 
In the heart tissue, factors such as hypoxia, 
ischemic/reperfusion injury, hypertrophy, and pressure 
overload may activate the ER stress.29 It is reported that 
atorvastatin exerts possible mechanism in protecting the heart 
against heart failure via downregulation of ER stress 
response.30 Moreover, atorvastatin exert antiapoptotis by 
inhibiting the synthesis of mevalonate, which is the source of 
several isoprenoides involved in various intracellular events 
such as apoptosis and inflammation.31 Another possible 
cardioprotection mechanism of atorvastatin against apoptotis is 
the increased expression of CXC chemokines which are the 
two N-terminal cysteines of CXC chemokines (or α-
chemokines) are separated by one amino acid, represented in 
this name with an "X", such as SDF-1α and receptor CXCR4. 
Qiu et al. (2012) reported that the increased expression of SDF-
1α/CXCR4 axis, as a result of taking atorvastatin in infarcted 
rats, confers antiapoptotic effects.10 This finding is consistent 
with results of this study. In this study, the protein expression 
of SDF-1α/CXCR4 axis significantly increased compared to 
the control group as a result of atorvastatin intake. Thus, it can 
be claimed that some of the antiapoptotic effects of atorvastatin 
are presumably caused by the increased protein expression of 
SDF-1α/CXCR4 axis. 
Nevertheless, the combination of exercise and atorvastatin 
significantly increased the protein expression of SDF-
1α/CXCR4 axis. One of the associated mechanisms with 
boosting effects of combined therapy by exercise and 
atorvastatin in the expression of SDF-1α/CXCR4 is presumably 
due to their effects in increased eNOS activity and 
strengthening of NO production. It is reported that the 
overexpression of the eNOS/NO system via genetic or 
pharmaceutical interventions, leads to increased protein and 
mRNA expression of SDF-1α/CXCR4 axis.10 Thus, it is likely 
that, the effects of endurance training and atorvastatin in the 
upregulation of the eNOS/NO expression aggregate together 
and lead to additional positive effects on the protein expression 
of SDF-1α/CXCR4. 
In conclusion, the results of this study reported that the 
combined intervention of endurance training and atorvastatin in 
case of both apoptosis and protein expression has better 
efficacy than either drug or training individually. Thus, it is 
suggested that patients with cardiovascular disease along with 
medical therapy use the aerobic exercises as a powerful tool in 
strengthening their heart capacity and function; however, 
further investigation is warranted. 
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